From Cato Today <[email protected]>
Subject More FDA Regulations = Fewer COVID-19 Solutions
Date April 6, 2020 11:06 AM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
The WTO could help international cooperation in trading medical supplies. The FDA's expansion has hurt the fight against COVID-19.

View in browser ([link removed] )

April 6, 2020

Coronavirus - sized ([link removed] )

FDA Growth Hinders the Fight Against COVID-19 ([link removed] )

Despite its growth over the last decade, the FDA has been more of a hindrance than a help in combating COVID-19. The expansion of the FDA is getting in the way.

- FDA Bureaucracy Grows 79% Since 2007 ([link removed] )

By Chris Edwards

Metro ([link removed] )

Urban Transit Does Not Need a Bailout ([link removed] )

Instead of bailing out transit, it’s time to start thinking about phasing out the subsidies we give it.

- COVID-19 Is No Excuse to Bail out Urban Transit ([link removed] )

By Randal O'Toole

FEATURED ARTICLES

Yemen Is Shattered and the U.S. Helped the Saudis Break It ([link removed] )

Even with a cease‐​fire on the horizon Yemen may never recover, thanks to the renewed Western support for the Kingdom of Saudi Arabia.

Read More ([link removed] )

Do Great Leaders Create Peace and Prosperity? ([link removed] )

“Great leaders” get written about, but “do‐​nothing” officials may generate more peace, prosperity, and happiness.

Read More ([link removed] )

Governments Should Rely More on the WTO in the Fight Against the Coronavirus ([link removed] )

WTO members can promote freedom of trade between countries. Decreasing trade regulation would encourage international cooperation in the fight against COVID-10.

Read More ([link removed] )

Sign Up For Other Cato Newsletters ([link removed] )

SUPPORT CATO ([link removed] )

Facebook ([link removed] )

LinkedIn ([link removed] )

Twitter ([link removed] )

Instagram ([link removed] )

YouTube ([link removed] )

Cato Institute, 1000 Massachusetts Ave, NW, Washington, DC 20001, (202) 842-0200

Manage preferences ([link removed] )
Screenshot of the email generated on import

Message Analysis